IRadimed
IRMD
#5609
Rank
NZ$2.15 B
Marketcap
NZ$168.98
Share price
-0.32%
Change (1 day)
90.71%
Change (1 year)
Categories

Market capitalization of IRadimed (IRMD)

Market cap: NZ$2.15 Billion

As of April 2026 IRadimed has a market cap of NZ$2.15 Billion. This makes IRadimed the world's 5609th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of IRadimed from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$2.15 B0.91%
2025NZ$2.14 B74.23%
2024NZ$1.22 B29.84%
2023NZ$0.94 B68.99%
2022NZ$0.55 B-34.02%
2021NZ$0.84 B118.2%
2020NZ$0.38 B-4.78%
2019NZ$0.40 B1.93%
2018NZ$0.40 B77.97%
2017NZ$0.22 B31.17%
2016NZ$0.17 B-62.49%
2015NZ$0.45 B157.04%
2014NZ$0.17 B

End of Day market cap according to different sources

On Apr 5th, 2026 the market cap of IRadimed was reported to be:

NZ$2.15 Billion
by Nasdaq info icon info icon
NZ$2.15 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Edwards Lifesciences
EW
NZ$82.66 B 3,726.93%๐Ÿ‡บ๐Ÿ‡ธ USA
NuVasive
NUVA
NZ$3.66 B 69.49%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
NZ$42.61 B 1,872.80%๐Ÿ‡บ๐Ÿ‡ธ USA
AtriCure
ATRC
NZ$2.54 B 17.72%๐Ÿ‡บ๐Ÿ‡ธ USA